sns insider pvt ltd.png
Heart Failure POC & LOC Devices Market to Hit USD 401.91 Million by 2032, Growing at 17.26% CAGR | Research by SNS Insider
07 déc. 2024 08h00 HE | SNS Insider pvt ltd
Austin, United States, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Heart Failure POC & LOC Devices Market Size & Growth Analysis: “According to SNS Insider, The Heart Failure POC & LOC Devices...
22157.jpg
Chronic Heart Failure Epidemiology Forecasts, 2020-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
27 nov. 2024 10h54 HE | Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Chronic Heart Failure - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.This report delivers an in-depth...
35Pharma 1a.png
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
26 nov. 2024 08h00 HE | 35Pharma Inc.
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
e-therapeutics_primary_logo.png
e-therapeutics Announces Business Updates and Interim Results
31 oct. 2024 09h00 HE | e-therapeutics plc
LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced business...
22157.jpg
Angina Global Market Report 2024: A $13.61 Billion Market in 2028, Registering a Compound Annual Growth Rate (CAGR) of 6.2%
04 sept. 2024 09h26 HE | Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Angina Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The angina market size has grown strongly in recent years, from...
Global Market for Acute Heart Failure (AHF) Therapeutics
Acute Heart Failure (AHF) Therapeutics Global Strategic Business Report 2022-2024 and 2030 - The Litany of Drug Failures Expands, Emphasis on Prevention Grows
01 mars 2024 06h25 HE | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Acute Heart Failure (AHF) Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Acute...
22157.jpg
Cardiac Resynchronization Therapy Market Set To Grow, New Study Reveals Key Drivers and Trends Shaping the Future
15 févr. 2024 12h04 HE | Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Resynchronization Therapy Market Report by Type, Application, End User, and Region 2023-2028" report has been added to ...
Global Artificial Intelligence In Cardiology Market
Artificial Intelligence in Cardiology Market Set for Rapid Growth, Forecast 2024-2034: Emphasis on Advanced Diagnostic Solutions with CAGR of 34.14%
29 janv. 2024 06h05 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence In Cardiology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Cardiovascular Perfusion Disposables Market: Rapid Growth Forecast Revealed till 2033
24 janv. 2024 01h48 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Daxor logo thumbnail.png
New Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure Patients
13 nov. 2023 08h00 HE | Daxor Corporation
Data From Study Funded by NIH Presented at the American Heart Association Annual Meeting Oak Ridge, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...